Elisabeth Sandoval Procept Bio Robotics Corp (PRCT) insider trading activity

Elisabeth Sandoval is Director of PROCEPT BioRobotics Corp. Currently has a direct ownership of 12,561 shares of PRCT, which is worth approximately $738,084. The most recent transaction as insider was on Jun 10, 2025, when has been sold 1,538 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.6K

13.95% 3M change

13.95% 12M change

Total Value Held $738,084

Elisabeth Sandoval Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 10 2025	BUY Grant, award, or other acquisition	-	1,538 Added 10.91%	12,561 Common Stock
Jun 04 2024	BUY Grant, award, or other acquisition	-	1,376 Added 11.1%	11,023 Common Stock
Jun 15 2023	BUY Grant, award, or other acquisition	-	2,711 Added 21.94%	9,647 Common Stock
Jun 07 2022	BUY Grant, award, or other acquisition	$74,997 $37.48 p/Share	2,001 Added 22.39%	6,936 Common Stock
Oct 21 2021	BUY Grant, award, or other acquisition	$199,670 $40.46 p/Share	4,935 Added 50.0%	4,935 Common Stock

Also insider at

STSA

Satsuma Pharmaceuticals, Inc. Healthcare

Director

VYNE

VYNE Therapeutics Inc. Healthcare